A bill to allow the sponsor of an application for the approval of a targeted drug to rely upon data and information with respect to such sponsor's previously approved targeted drugs.
The bill’s titles are written by its sponsor.
Sep 15, 2015
114th Congress, 2015–2017
Died in a previous Congress
This bill was introduced on February 9, 2016, in a previous session of Congress, but was not enacted.
Senator from Colorado
Read Text »
Last Updated: Apr 5, 2016
Length: 10 pages
This is the first step in the legislative process.
Ordered Reported by Committee
A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.
S. 2030 (114th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 114th Congress, which met from Jan 6, 2015 to Jan 3, 2017. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
Civic Impulse. (2017). S. 2030 — 114th Congress: Advancing Targeted Therapies for Rare Diseases Act of 2016. Retrieved from https://www.govtrack.us/congress/bills/114/s2030
“S. 2030 — 114th Congress: Advancing Targeted Therapies for Rare Diseases Act of 2016.” www.GovTrack.us. 2015. May 24, 2017 <https://www.govtrack.us/congress/bills/114/s2030>
|title=S. 2030 (114th)
|accessdate=May 24, 2017
|author=114th Congress (2015)
|date=September 15, 2015
|quote=Advancing Targeted Therapies for Rare Diseases Act of 2016
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.